Technical Analysis for VRDN - Viridian Therapeutics, Inc.

Grade Last Price % Change Price Change
F 14.34 -0.83% -0.12
VRDN closed down 0.83 percent on Thursday, April 15, 2021, on 88 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical VRDN trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup -0.83%
Stochastic Reached Oversold Weakness -0.83%
Below Lower BB Weakness -0.83%
Lower Bollinger Band Touch Weakness -0.83%
Oversold Stochastic Weakness -0.83%
Inside Day Range Contraction -6.70%
Lower Bollinger Band Touch Weakness -8.84%
Older End-of-Day Signals for VRDN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 18 hours ago
Rose Above Lower Bollinger Band about 19 hours ago
3x Volume Pace about 19 hours ago
2x Volume Pace about 19 hours ago
1.5x Volume Pace about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado, with research and development operations in Waltham, Massachusetts.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biology Monoclonal Antibody Serious Diseases Thyroid Eye Disease

Is VRDN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 25.67
52 Week Low 7.05
Average Volume 34,418
200-Day Moving Average 16.15
50-Day Moving Average 17.52
20-Day Moving Average 16.65
10-Day Moving Average 15.72
Average True Range 1.06
ADX 14.25
+DI 16.15
-DI 29.72
Chandelier Exit (Long, 3 ATRs ) 15.47
Chandelier Exit (Short, 3 ATRs ) 17.53
Upper Bollinger Band 19.00
Lower Bollinger Band 14.30
Percent B (%b) 0.01
BandWidth 28.21
MACD Line -0.76
MACD Signal Line -0.53
MACD Histogram -0.2269
Fundamentals Value
Market Cap 56.08 Million
Num Shares 3.91 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -11.11
Price-to-Sales 27.55
Price-to-Book 3.09
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.32
Resistance 3 (R3) 15.42 15.21 15.15
Resistance 2 (R2) 15.21 14.96 15.15 15.10
Resistance 1 (R1) 14.77 14.80 14.67 14.67 15.04
Pivot Point 14.56 14.56 14.50 14.50 14.56
Support 1 (S1) 14.12 14.31 14.02 14.02 13.64
Support 2 (S2) 13.91 14.15 13.85 13.58
Support 3 (S3) 13.47 13.91 13.53
Support 4 (S4) 13.37